The New York State Department of Health said Thursday that the new focus of its investigation into vaping-associated lung illnesses is vitamin E acetate.
Almost all cannabis-containing samples that were examined by the Wadsworth Center had high levels of vitamin E acetate, which is not an approved additive for New York State Medical Marijuana Program-authorized vape products, the Department of Health said.
Nicotine-based products that were also tested were free of vitamin E acetate, the regulatory agency said.
Even though vitamin E acetate is known as a common nutritional supplement and can be safely ingested or applied to the skin, the consequences of inhaling it are largely unknown, the agency said.
When the vitamin is "inhaled deep in the lung, [it] can cause problems," New York Health Commissioner Dr. Howard Zucker told NPR.
The investigation is ongoing and that it hasn’t ruled out other substances, while the Food and Drug Administration doubts that vitamin E is the main culprit, according to NPR.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
"More information is needed to better understand whether there's a relationship between any specific products or substances and the reported illnesses," Michael Felberbaum, FDA senior adviser, said in an emailed statement to NPR.
The FDA now has more than 100 samples available for testing, he said.
"The FDA is analyzing samples submitted by the states for the presence of a broad range of chemicals, including nicotine, THC and other cannabinoids along with cutting agents/diluents and other additives, pesticides, opioids, poisons and toxins. No one substance, including Vitamin E acetate, has been identified in all of the samples."
The New York Department of Health warned the public never to buy “off-the-street” vaping products, as it turns out the cartridges they tested seem to be black market products.
The agency advised that anyone who uses any vaping product and experiences unusual symptoms to call their doctor.
The symptoms reported by patients who use vape products include: lung-related symptoms, such as cough, chest pain, and shortness of breath; gastrointestinal symptoms such as vomiting, nausea and diarrhea; fatigue; headache; fever; and weight loss.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.